Aristotle University Of Thessaloniki (AUTH)
Ανάπτυξη νανοφορέων για τη στοματική και οφθαλμική χορήγηση θεραπευτικών βιομορίων
Abstract
dc:descriptionThe primary aim of this thesis was the development of mucus permeating nanocarriers according to alternative mucus penetration strategies (e.g., controlled release of mucolytic agents, immobilization of proteolytic enzymes, etc.), that focus on the local and selective disruption of the mucus layer, thus facilitating the transport of nanocarriers and allowing them to deliver their therapeutic payload to the epithelium or to be uptaken by the epithelial cells. Additionally, a state-of-the-art mucus permeating nanocarrier-based system for controlled delivery of insulin was presented and critically assessed. Furthermore, the lack of efficient and safe gene delivery systems was addressed throughout this study. Two types of cationic liposomes (i.e., lipoplexes) were investigated for the therapeutic ocular gene delivery. More specifically, the first part of this thesis deals with the surface functionalization of poly(lactic-co-glycolide) PLGA nanoparticles with various proteolytic enzymes (i.e., trypsin, papain, bromelain) via a two-step carbodiimide coupling method. The enzyme-functionalized PLGA NPs were fully characterized with respect to their morphology, particle size distribution (PSD), zeta potential, enzyme conjugation efficiency, storage stability, effect on cell viability, enzymatic and mucolytic activity and their ability to permeate mucus. Furthermore, the mucolytic agent 4-mercaptobenzoic acid (4-MBA) was encapsulated in PLGA nanoparticles, as well as in liposomes, aiming to achieve controlled release of the mucolytic agent and, consequently, efficient transport of the nanocarriers through the mucus mesh. The effect of the initial concentration of 4-MBA on the properties of the produced NPs (i.e., average particle size, encapsulation efficiency of the mucolytic agent, release profile of 4-MBA from the nanoparticles) was examined. The 4-MBA loaded PLGA NPs were fully characterized with respect to their morphology, storage stability and effect on cell viability. Pegylated and non-pegylated liposomes containing 4-MBA were prepared by the hydration/extrusion method. The effect of the liposome composition (i.e., lipids combination and molar ratios) on the properties of the produced liposomes (i.e., average size, incorporation efficiency and release of the mucolytic agent) was examined. Moreover, a novel bifunctional liposomal formulation that incorporates the mucolytic agent 4-MBA in the lipid bilayers and a protein drug in the aqueous compartment was presented. Finally, the permeation rate of the 4-MBA nanocarriers was experimentally assessed in fresh porcine intestinal mucus. Additionally, a novel mucus permeating nanoemulsion for oral insulin delivery, incorporating a hydrophobic ion pair (HIP) of insulin/dimyristoyl phosphatidyl glycerol (INS/DMPG) was developed. The anionic lipid emulsions (ALEs) were examined with respect to mucus permeability, storage stability and effect on cell viability. Finally, the release of insulin from ALEs and their behavior in GIT conditions were experimentally investigated. Finally, throughout this study, the use of cationic liposomes for the effective ocular gene delivery was assessed. A comparative study of the physicochemical properties, DNA binding ability and transfection efficiency between freshly prepared pegylated and non-pegylated lipoplexes was conducted. Two lipoplexes formulations, one containing the cationic lipid, dimethyldioctadecylammonium bromide (DDAB) and the co-lipid cholesterol (CHOL) (DDAB:CHOL, 1:1) and the other containing additionally the pegylated lipid DSPE-PEG2000 (DDAB:CHOL:DSPEPEG2000, 1:1:0.04) were critically examined.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Samaridou, Eleni
- Σαμαρίδου, Ελένη
Subjects
dc:subject × 18- Στοματική χορήγηση βιομορίων
- Οφθαλμική χορήγηση βιομορίων
- Νανοφορείς
- ΒΛΕΝΝΑ
- Βλεννολυτικοί παράγοντες
- Διάβαση της βλέννας
- C ΠΕΠΤΙΔΙΟ - ΙΝΣΟΥΛΙΝΗ
- Oral drug delivery
- Ocular drug delivery
- Nanobased drug delivery systems
- Mucus permeation
- Oral delivery of insulin
- Επιστήμες Μηχανικού και Τεχνολογία
- Επιστήμη Χημικού Μηχανικού
- Νανοτεχνολογία
- Engineering and Technology
- Chemical Engineering
- Nano-Technology
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/36672